Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 665.1	$ 745.4	$ 865.0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	324.4	308.6	294.8
Share based compensation	77.4	87.1	75.7
Change in fair value of contingent consideration	(159.1)	9.2	0
Impairment of intangible assets	19.9	197.9	16.0
Goodwill impairment charge	7.1	0	0
Impairment of assets held for sale	636.9	0	0
Write down of assets	58.2	0.9	0
Gain on sale of non-current investments	0	0	(23.5)
(Gain)/ loss on sale of product rights	(15.9)	(18.1)	6.0
Other, net	8.3	7.4	16.1
Movement in deferred taxes	(349.9)	(58.3)	(14.5)
Equity in earnings of equity method investees	(3.9)	(1.0)	(2.5)
Changes in operating assets and liabilities:
(Increase)/decrease in accounts receivable	(148.3)	22.2	(134.0)
Increase in sales deduction accruals	177.5	42.7	80.5
Increase in inventory	(36.6)	(88.2)	(64.4)
Increase in prepayments and other assets	(60.9)	(14.5)	(36.8)
Increase/(decrease) in accounts payable and other liabilities	67.9	136.7	(10.0)
Returns on investment from joint venture	3.1	4.9	5.2
Net cash provided by operating activities	1,463.0	1,382.9	1,073.6
CASH FLOWS FROM INVESTING ACTIVITIES:
Movements in restricted cash	(5.3)	3.5	6.2
Purchases of subsidiary undertakings and businesses, net of cash acquired	(227.8)	(97.0)	(725.0)
Purchases of non-current investments	(10.6)	(18.0)	(10.7)
Purchases of property, plant and equipment ("PP&E")	(157.0)	(149.6)	(194.3)
Purchases of intangible assets	0	(43.5)	(5.2)
Proceeds from disposal of non-current investments and PP&E	12.1	7.2	106.0
Proceeds received on sale of product rights	19.2	17.8	12.0
Returns from equity investments	5.4	0	0
Other, net	3.1	8.6	1.8
Net cash used in investing activities	(360.9)	(271.0)	(809.2)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments to acquire shares (in USD)	(243.8)	(205.8)	(151.8)
Payment of dividend	(96.4)	(86.3)	(73.8)
Proceeds from exercise of options	17.2	16.2	13.4
Proceeds from drawing of revolving credit facility ("RCF")	0	0	30.0
Repayment of RCF	0	0	(30.0)
Repayment of debt acquired through business combinations	(6.0)	0	(13.1)
Facility arrangement fee	(13.9)	0	0
Excess tax benefit associated with exercise of stock options	13.4	40.7	31.4
Contingent consideration payments	(14.1)	(5.8)	0
Other, net	(1.0)	(3.3)	(1.5)
Net cash used in financing activities	(344.6)	(244.3)	(195.4)
Effect of foreign exchange rate changes on cash and cash equivalents	(0.3)	(5.4)	0.4
Net increase in cash and cash equivalents	757.2	862.2	69.4
Cash and cash equivalents at beginning of period	1,482.2	620.0	550.6
Cash and cash equivalents at end of period	2,239.4	1,482.2	620.0
Supplemental information associated with continuing operations:
Interest paid	(29.9)	(34.6)	(33.3)
Income taxes paid	(290.2)	(199.2)	(286.1)
Continung operations
Adjustments to reconcile net income to net cash provided by operating activities:
Goodwill impairment charge	7.1
Discontinued operations
Adjustments to reconcile net income to net cash provided by operating activities:
Goodwill impairment charge	191.8
Goowill impairment charge total
Adjustments to reconcile net income to net cash provided by operating activities:
Goodwill impairment charge	198.9
EBT
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments to acquire shares (in USD)	(50.0)	(99.3)	(151.8)
Share Buy-back Program
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments to acquire shares (in USD)	$ (193.8)	$ (106.5)	$ 0